The α1 and α6 Subunits Can Coexist in the Same Cerebellar GABAA Receptor Maintaining Their Individual Benzodiazepine-Binding Specificities |
| |
Authors: | Zafar U Khan Antonia Gutiérrez Angel L De Blas |
| |
Institution: | Division of Molecular Biology and Biochemistry, School of Biological Sciences, University of Missouri-Kansas City, Kansas City, Missouri, U.S.A. |
| |
Abstract: | Abstract: Two GABAA receptor subunit-specific antibodies anti-α6 and anti-α1 have been used for elucidating the relationship between the presence of α1 and/or α6 subunits in the cerebellar GABAA receptors and the benzodiazepine-binding specificity. Receptor immunoprecipitation with the subunit-specific antibodies shows that 39% of the cerebellar GABAA receptors have α6, whereas 76% of the receptors have α1 as determined by 3H]muscimol binding. Results show that 42–45% of the receptors having α6 also have α1, whereas 13–15% of the receptors that contain α1 also have α6. The immunoprecipitation results as well as immunopurification and immunoblotting experiments reveal the existence of three types of cerebellar GABAA receptors; i.e., one has both α1 and α6 subunits, a second type has α1 but not α6, and a third type has α6 but not α1 subunits. The results also show that receptors where α1 and α6 subunits coexist have two pharmacologically different benzodiazepine-binding properties, each associated with a different α subunit. The α1 subunit contributes the high-affinity binding of 3H]Ro 15-1788 (flumazenil) and the diazepam-sensitive binding of 3H]Ro 15-4513. The α6 subunit contributes the diazepam-insensitive binding of 3H]Ro 15-4513, but it does not bind 3H]Ro 15-1788 with high affinity. Thus, in the cerebellar α1–α6 GABAA receptors, there is no dominance of the pharmacology of one α subunit over the other. |
| |
Keywords: | GABAA receptor Benzodiazepine receptor Antibody Pharmacology Structure |
|
|